Dr. John Kaczmar with a colleague

Hematology & Oncology

At the forefront of cancer research, the MUSC Hollings Cancer Center (HCC) is one of 72 National Cancer Institute-designated cancer centers in the nation and the only one in South Carolina. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public and to establish outreach services for underserved populations across the state.

As an integral component of the Hollings Cancer Center, the MUSC Division of Hematology & Oncology builds upon a long history of excellence in hematology and hematological malignancies, as well as solid tumor oncology and bone marrow transplant. Division faculty are leaders in the fields of cancer care and blood disorders. In the latest rankings by U.S. News & World Report, MUSC Health's Hematology/Oncology program ranked as high-performing for the treatment of cancer.

Education

The Division’s fellowship program continues to recruit top tier candidates and is the only hematology oncology training program in the state of South Carolina. The program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation.  

Learn more about our Hematology & Oncology Fellowship Program

Research

The Division's faculty members are equally committed to research and lead efforts in the laboratory as well as conduct clinical trials. Our comprehensive treatment protocols include an ever-expanding clinical trials portfolio offering studies for most types of cancer and blood disorders. As an NCI-Designated Cancer Center, Hollings offers clinical trials and therapies not available elsewhere in South Carolina.

Learn more about our Research Program

Patient Care

The Division specializes in a wide range of malignant diseases and blood disorders and serves as a statewide referral center for solid tumor oncology, malignant and benign hematology, and bone marrow transplant. The dynamic clinical team of the MUSC Division of Hematology & Oncology is committed to providing exceptional patient care in oncology, malignant and benign hematology, and bone marrow transplant. Our clinical faculty see patients at the Hollings Cancer Center, the Ralph H. Johnson VA Medical Center, Medical University Hospital and Ashley River Tower.

Learn more about our Patient Care services